| Gene symbol | PDGFB | Synonyms | IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | Type of gene | protein-coding |
| Chromosome | 22 | Map location | 22q13.1 | dbXrefs | |
| Description | platelet derived growth factor subunit B | ||||
| GTO ID | GTC1562 |
| Trial ID | NCT02591914 |
| Disease | Age-Related Macular Degeneration |
| Altered gene | PDGFB |
| Therapeutic/Target gene | Target gene |
| Therapy | Aptamer |
| Treatment | E10030|Fovista|anti-PDGF BB |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration |
| Year | 2014 |
| Country | United States |
| Company sponsor | Retinal Consultants of Arizona |
| Other ID(s) | E10030-003 |
| Cohort 1 | |||||||
|
|||||||